⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BRTX News
BioRestorative Therapies, Inc. Common Stock (NV)
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
globenewswire.com
BRTX
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
globenewswire.com
BRTX
Form 8-K
sec.gov
BRTX
Form 8-K
sec.gov
BRTX
Form 8-K
sec.gov
BRTX
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)
prnewswire.com
BRTX
BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline Data
globenewswire.com
BRTX
BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticals
globenewswire.com
BRTX
BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease
globenewswire.com
BRTX
Form 8-K
sec.gov
BRTX